A team of physicists at the Institut Lumière Matière (CNRS/Université Claude Bernard Lyon 1), in collaboration with the Cancer Research Center of Lyon (CNRS/INSERM/ Université Claude Bernard Lyon 1/Centre Léon Bérard/Hospices civils de Lyon), has demonstrated the potential, for oncology, of an imaging technique based only on the physical properties of tumors. It can differentiate populations of malignant cells and monitor how effective an anticancer treatment is. These results, published in Physical Review Letters on January 8, 2019, should help in the design of new therapeutic molecules and in the personalization of treatments.
Despite a good understanding of the biology of cancer, 90% of experimental drugs fail during clinical trials. It is also increasingly suspected that the mechanical properties of tumors influence disease progression, and treatment efficacy. Although we can evaluate tumor elasticity globally, it is more difficult to measure local rigidity deep down and to see whether the core of the tumor resists the penetration of therapeutic liquids. To probe these physical properties, the researchers have used a noncontact imaging technique that does not require the use of contrast agents – therefore that does not disturb tissue function – that exploits natural infinitesimal vibrations of matter.
To recapitulate the behavior of colorectal tumors in vitro, the researchers created organoids, spheres with diameter 0.3 mm formed by the aggregation of tumor cells. They focused a red laser beam onto these objects. The infinitesimal vibrations of the sample, generated by thermal agitation, modify very slightly the color of the light beam that exits the sample. By analyzing this light, a map of the mechanical properties of the model tumors is created: the more rigid the area scanned by the laser, the faster the vibrations and, in a manner comparable to the Doppler effect (the mechanism that makes a siren sound increasingly shrill as it gets closer), the greater the color change.
From organoids composed of two cell lines with different malignancies, the researchers have shown that they could distinguish the two cell types from their mechanical properties. Such information is crucial because it may allow diagnosis from biopsy analysis to be refined and offer better assessment of tumor grade. Local variations in mechanical properties after a drug treatment have also been monitored using this technique: the center of the tumor remains rigid longer than the edge, demonstrating the treatment’s efficacy gradient. So local measurement of mechanical properties could confirm the total destruction of the tumor and help in choosing as low a treatment dose and duration as possible.
This approach allows exploring the impact of mechanical properties on the therapeutic response. It should lead to more predictive in vitro tumor models for testing new therapeutic molecules and for combined therapies, which act for example on tissue rigidity to accelerate the penetration of active molecules in the center of the tumor. It could also provide new indicators to guide clinicians in personalization of therapies.
Learn more: Physics can show us the inside of tumors
The Latest on: Personalized cancer treatment
via Google News
The Latest on: Personalized cancer treatment
- Killing cancer by unleashing the body's own immune systemon January 12, 2021 at 6:07 pm
The body's immune system is the first line of defense against infections like bacteria, viruses or cancers. Some cancers, however, have developed the art of molecular deception to avoid destruction by ...
- XCures announces collaboration with CancerCompass to better support patients and caregivers through their cancer journeyon January 12, 2021 at 3:46 pm
At CancerCompass, we believe that cancer is personal and that treatment options and journeys should be individualized to align with each patient’s needs and preferences”— ...
- What People With Cancer Should Know about the COVID-19 Vaccineson January 12, 2021 at 3:44 pm
The COVID-19 pandemic has been especially difficult for people with cancer, their families, and caregivers. We understand many of you have questions about if and when you should get the COVID-19 ...
- The Perfect Cancer Resource Didn’t Exist When She Needed It, So This 30-Year-Old Survivor Created Her Ownon January 12, 2021 at 2:41 pm
She was 29 years old. What followed was a long, hard fight that included 800 hours of chemotherapy, 20 radiation sessions, and an autologous stem cell transplant. A little over a year later, on ...
- Johnson Assumes Director Post of Lung Cancer Research at Sarah Cannon Research Instituteon January 12, 2021 at 10:19 am
Melissa Johnson, MD, shares her goals for the first 100 days as program director of the Lung Cancer Research at Sarah Cannon Research Institute, the current state of the anti-TIGIT antibody ...
- Big data analysis finds cancer's key vulnerabilitieson January 12, 2021 at 7:44 am
A new analysis of almost 10,000 patients found that tumors could be stratified into 112 subtypes regardless of the cancer's origin.
- Natera to Present New Colorectal Cancer Data at the 2021 ASCO GI Symposiumon January 12, 2021 at 6:03 am
PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will present new data on its ...
- Nobel prizewinner Ciechanover hails ‘much more precise’ cancer treatmenton January 11, 2021 at 11:51 pm
With multi-center clinical trials in Israel, US and UK, Israeli startup OncoHost hopes to launch life-saving test kit in 2021 ...
- Master Regulator proteins control cancer transcriptional identityon January 11, 2021 at 4:44 pm
Thousands of different genetic mutations have been implicated in cancer, but a new analysis of almost 10,000 patients found that regardless of the cancer's origin, tumors could be stratified in only ...
- Alula, a platform for cancer caregivers, patients and survivors, raises $2.2 millionon January 11, 2021 at 6:49 am
According to the National Cancer Institute, some 1.8 million people are diagnosed with cancer each year in the U.S. alone. Factor in the friends, family and loved ones of those patients, and the ...
via Bing News